Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.54 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.54 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.54 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | PYGB | P11216 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ribose (Furanose) SCHEMBL15814845 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL14349491 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL447758 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL16199379 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL24087736 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL66645 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL23017520 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL109435 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL7618455 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL13135754 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230271995-A1 | METHODS FOR PRODUCING DIHYDRONICOTINAMIDE RIBOSIDE FROM NICOTINAMIDE RIBOSIDE CHLORIDE | NESTLE SA (CH) | 2023-08-31 | — | — | US | disclosed |
| WO-2017075590-A2 | PROCESSES FOR PREPARING 2-DIHALO RIBOLACTONES | COCRYSTAL PHARMA, INC. (US) | 2017-05-04 | — | — | WO | disclosed |
| US-20170066787-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. | 2017-03-09 | — | — | US | disclosed |
| US-20170056528-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | MODERNATX, INC. | 2017-03-02 | — | — | US | disclosed |
| US-9566289-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2017-02-14 | — | — | US | disclosed |
| US-9428535-B2 | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof | MODERNA THERAPEUTICS, INC. (US) | 2016-08-30 | — | — | US | disclosed |
| US-20160151399-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. | 2016-06-02 | — | — | US | disclosed |
| US-20130130936-A1 | Method of Conducting an Assay | ADVANCED LIQUID LOGIC, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130123481-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | modeRNA Therapeutics (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130115272-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | modeRNA Therapeutics (US) | 2013-05-09 | — | — | US | disclosed |
| US-7767657-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2010-08-03 | — | — | US | disclosed |
| US-20090076142-A1 | USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-03-19 | — | — | US | disclosed |
| US-20080081905-A1 | Preparation and uses of locked-ring sugar C-glycoside derivatives | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2008-04-03 | — | — | US | disclosed |
| WO-2007133908-A2 | USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2007-11-22 | — | — | WO | disclosed |
| WO-2007113841-A2 | NOVEL AMINOGLYCOSIDES AND USES THEREOF IN THE TREATMENT OF GENETIC DISORDERS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2007-10-11 | — | — | WO | disclosed |
| US-20070197460-A1 | RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION | ALNYLAM PHARMACEUTICALS, INC. (US) | 2007-08-23 | — | — | US | disclosed |
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
| WO-2007053696-A2 | RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION | ALNYLAM PHARMACEUTICALS, INC. (US) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007047793-A2 | CYCLOPENTENOL NUCLEOSIDE COMPOUNDS, INTERMEDIATES FOR THEIR SYNTHESIS AND METHODS OF TREATING VIRAL INFECTIONS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070000781-A1 | ENZYME IMMOBILIZATION FOR ELECTROOSMOTIC FLOW | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081905-A1 | Preparation and uses of locked-ring sugar C-glycoside derivatives | GCK, KHK, HK1 | LGALS1 1508/4885LGALS3 1775/4885LGALS9 2838/4885 |
| US-20130123481-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | ADAR, NT5C3B, NSUN2 | LGALS1 2323/4885LGALS3 1820/4885LGALS9 855/4885 |
| US-20170066787-A1 | BORON-CONTAINING SMALL MOLECULES | ETF1, POLR1C, DPM1 | LGALS1 1549/4885LGALS3 1237/4885LGALS9 1920/4885 |
| US-20170056528-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | ADAR, NT5C3B, NSUN2 | LGALS1 2323/4885LGALS3 1820/4885LGALS9 855/4885 |
| US-20070000781-A1 | ENZYME IMMOBILIZATION FOR ELECTROOSMOTIC FLOW | MGAM, PNKP, AGL | LGALS1 2581/4885LGALS3 1737/4885LGALS9 2344/4885 |
| US-20160151399-A1 | BORON-CONTAINING SMALL MOLECULES | ETF1, POLR1C, DPM1 | LGALS1 1549/4885LGALS3 1237/4885LGALS9 1920/4885 |
| US-20070197460-A1 | RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION | SNRPE, EIF2AK2, AGO2 | LGALS1 2442/4885LGALS3 2338/4885LGALS9 2622/4885 |
| US-20090076142-A1 | USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS | OXER1, TRPA1, NR1H3 | LGALS1 4004/4885LGALS3 4106/4885LGALS9 4308/4885 |
| US-20230271995-A1 | METHODS FOR PRODUCING DIHYDRONICOTINAMIDE RIBOSIDE FROM NICOTINAMIDE RIBOSIDE CHLORIDE | NRDC, NAMPT, NNT | LGALS1 4807/4885LGALS3 4814/4885LGALS9 4654/4885 |
| US-20070155699-A1 | Boron-containing small molecules | ETF1, POLR1C, DPM1 | LGALS1 1549/4885LGALS3 1237/4885LGALS9 1920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.